North America and Europe Stroke Diagnostics– our new study reveals trends, R&D progress, and predicted revenues
Where is the North America and Europe Stroke Diagnostics market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 150+ page report provides xx tables, xx charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing North America and Europe Stroke Diagnostics Market. See how to exploit the opportunities.
Forecasts to 2030 and other analyses reveal the commercial prospects
– In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
– You find original analyses, with business outlooks and developments.
– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the North American and European market and submarkets
Along with revenue prediction for the overall North American and European market, there are 1 segmentation of the North America and Europe Stroke Diagnostics market, with forecasts for 6 Technologies, each forecasted at country level.
North America and Europe Stroke Diagnostics Market by Technology
– Carotid Ultrasound
– Cerebral Angiography
– Computed Tomography Scan
– Magnetic Resonance Imaging
– Nuclear Imaging
– Others
In addition to the revenue predictions for the overall North American and European market and segments, you will also find revenue forecasts for 2 regional and 8 leading national markets:
– North America:
– U.S.
– Canada
– Europe:
– Germany
– France
– UK
– Italy
– Spain
– Russia
– Rest of Europe
The report also includes profiles and for some of the leading companies in the North America and Europe Stroke Diagnostics market, with a focus on this segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, U.S., Germany, and UK in particular, will continue to achieve high revenue growth to 2030.
Leading companies and the potential for market growth
Overall revenue for North America and Europe Stroke Diagnostics Market will surpass $2 billion in 2025, our work calculates. We predict strong revenue growth through to 2030.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the North America and Europe Stroke Diagnostics Market report helps you
In summary, our 150+ page report provides you with the following knowledge:
– Revenue forecasts to 2030 for 1 segmentation of the North America and Europe Stroke Diagnostics market, with forecasts for 6 Technologies, each forecasted at country level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
– Revenue forecasts to 2030 for 2 regional and 8 key national markets – See forecasts for the North America and Europe Stroke Diagnostics market in North America and Europe. Also forecasted is the market in the US, Canada, Germany, France, UK, Italy, Spain and Russia.
– Prospects for established firms and those seeking to enter the market– including company profiles for 14 major companies involved in the North America and Europe Stroke Diagnostics market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the North America and Europe Stroke Diagnostics market and leading companies. You will find data, trends and predictions.
Get our report today North America and Europe Stroke Diagnostics Market Forecast 2020-2030: Revenue Prospects by Technology (Carotid Ultrasound, Cerebral Angiography, Computed Tomography Scan, Magnetic Resonance Imaging, Nuclear Imaging, Others), and Geography.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. North America and Europe Stroke Diagnostics Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. North America and Europe Stroke Diagnostics Market Size and Forecast
2.3. Market Dynamics
2.3.1. Market Drivers
2.3.1.1. Rising geriatric population
2.3.1.2. Growing awareness towards early diagnosis
2.3.1.3. Growing adoption of unhealthy lifestyle
2.3.1.4. Growing healthcare expenditure
2.3.1.5. Technological advancements in diagnosis and surgical equipment
2.3.2. Market Restraints
2.3.2.1. Decline in the stroke incidence rates
2.3.3. North America and Europe Stroke Diagnostics Market: Trends
2.3.4. Mergers and Acquisitions
2.3.5. Entry of New Market Players
3. North America and Europe Stroke Diagnostics Market Analysis and Forecast, By Technology
3.1. Introduction
3.1.1. North America and Europe Stroke Diagnostics Market, Annual Growth Rate Comparison, By Technology
3.2. North America and Europe Stroke Diagnostics Market Size and Forecast, By Technology
3.2.1. Carotid Ultrasound
3.2.2. Cerebral Angiography
3.2.3. Computed Tomography Scan
3.2.4. Magnetic Resonance Imaging
3.2.5. Nuclear Imaging
3.2.6. Others
3.3. North America and Europe Stroke Diagnostics Attractiveness Index, By Technology
4. North America and Europe Stroke Diagnostics Market Analysis and Forecast, By Region
4.1. Introduction
4.1.1. North America and Europe Stroke Diagnostics Market, Annual Growth Rate Comparison, By Region
4.1.2. North America and Europe Stroke Diagnostics Market Share Comparison, By Region (2018 & 2030)
4.2. North America and Europe Stroke Diagnostics Market Size and Forecast, By Region
4.2.1. North America (U.S., Canada)
4.2.2. Europe (UK, France, Germany, Italy, Spain, Russia, RoEU)
4.3. North America and Europe Stroke Diagnostics Market Attractiveness Index, By Region
5. North America Stroke Diagnostics Market Analysis and Forecast, 2020-2030
5.1. Introduction
5.1.1. North America North America and Europe Stroke Diagnostics Market
5.1.2. North America and Europe Stroke Diagnostics Market, Annual Growth Rate Comparison, By Country
5.2. North America Stroke Diagnostics Market Size and Forecast, By Country
5.2.1. The U.S. Stroke Diagnostics Market
5.2.2. Canada Stroke Diagnostics Market
5.3. North America Stroke Diagnostics Market Size and Forecast, By Technology
5.4. North America Stroke Diagnostics Market Attractiveness Index, By Country
6. Europe Stroke Diagnostics Market Analysis and Forecast, 2020-2030
6.1. Introduction
6.1.1. Europe Stroke Diagnostics Market
6.1.2. Europe Stroke Diagnostics Market, Annual Growth Rate Comparison, By Country
6.2. Europe Stroke Diagnostics Market Size and Forecast, By Country
6.2.1. U.K. Stroke Diagnostics Market
6.2.2. France Stroke Diagnostics Market
6.2.3. Germany Stroke Diagnostics Market
6.2.4. Italy Stroke Diagnostics Market
6.2.5. Spain Stroke Diagnostics Market
6.2.6. Russia Stroke Diagnostics Market
6.2.7. Rest of Europe Stroke Diagnostics Market
6.3. Europe Stroke Diagnostics Market Size and Forecast, By Technology
6.4. Europe Stroke Diagnostics Market Attractiveness Index, By Country
7. Leading Companies in the North America and Europe Stroke Diagnostics Market
7.1. Competition Dashboard
7.2. Company Share Analysis
7.3. Leading Players
7.4. Boston Scientific Corp.
7.4.1. Company Overview
7.4.2. Product Offerings
7.4.3. Financial Performance (2016-2018)
7.4.4. Recent Initiatives
7.5. Cordis Corporation
7.5.1. Company Overview
7.5.2. Product Offerings
7.5.3. Financial Performance (2016-2018)
7.5.4. Recent Initiatives
7.6. GE Healthcare
7.6.1. Company Overview
7.6.2. Product Offerings
7.6.3. Financial Performance (2016-2018)
7.6.4. Recent Initiatives
7.7. Hitachi Medical Systems
7.7.1. Company Overview
7.7.2. Product Offerings
7.7.3. Financial Performance (2016-2018)
7.7.4. Recent Initiatives
7.8. Neusoft Medical Systems
7.8.1. Company Overview
7.8.2. Product Offerings
7.8.3. Financial Performance (2016-2018)
7.8.4. Recent Initiatives
7.9. Philips Healthcare
7.9.1. Company Overview
7.9.2. Product Offerings
7.9.3. Financial Performance (2016-2018)
7.9.4. Recent Initiatives
7.10. Siemens Healthcare
7.10.1. Company Overview
7.10.2. Product Offerings
7.10.3. Financial Performance (2016-2018)
7.10.4. Recent Initiatives
7.11. Toshiba Medical Systems Corporation
7.11.1. Company Overview
7.11.2. Product Offerings
7.11.3. Financial Performance (2016-2018)
7.11.4. Recent Initiatives
7.12. Medtronic
7.12.1. Company Overview
7.12.2. Product Offerings
7.12.3. Financial Performance (2016-2018)
7.12.4. Recent Initiatives
7.13. Stryker
7.13.1. Company Overview
7.13.2. Product Offerings
7.13.3. Financial Performance (2016-2018)
7.13.4. Recent Initiatives
7.14. Merck Sharp & Dohme Corp.
7.14.1. Company Overview
7.14.2. Product Offerings
7.14.3. Financial Performance (2016-2018)
7.14.4. Recent Initiatives
7.15. Teleflex Incorporated
7.15.1. Company Overview
7.15.2. Product Offerings
7.15.3. Financial Performance (2016-2018)
7.15.4. Recent Initiatives
7.16. B. Braun Melsungen AG
7.16.1. Company Overview
7.16.2. Product Offerings
7.16.3. Financial Performance (2016-2018)
7.16.4. Recent Initiatives
7.17. AliveCor, Inc.
7.17.1. Company Overview
7.17.2. Product Offerings
7.17.3. Financial Performance (2016-2018)
7.17.4. Recent Initiatives
8. Conclusion
9. Glossary
LIST OF TABLES
Table 1 North America and Europe Stroke Diagnostics Market Size, By Region, 2020-2030 (USD Mn, CAGR%)
Table 2 North America and Europe Stroke Diagnostics Market Size, By Technology, 2020-2030 (USD Mn, CAGR%)
Table 3 North America: Stroke Diagnostics Market Size, By Country, 2020-2030 (USD Mn, CAGR%)
Table 4 North America: Stroke Diagnostics Market Size, By Technology, 2020-2030 (USD Mn, CAGR%)
Table 5 U.S. Stroke Diagnostics Market Size, By Technology, 2020-2030 (USD Mn, CAGR%)
Table 6 U.S. Stroke Diagnostics Market Size, By Segment B, 2020-2030 (USD Mn, CAGR%)
Table 7 Canada Stroke Diagnostics Market Size, By Technology, 2020-2030 (USD Mn, CAGR%)
Table 8 Europe: Stroke Diagnostics Market Size, By Country, 2020-2030 (USD Mn, CAGR%)
Table 9 Europe: Stroke Diagnostics Market Size, By Technology, 2020-2030 (USD Mn, CAGR%)
Table 10 Germany Stroke Diagnostics Market Size, By Technology, 2020-2030 (USD Mn, CAGR%)
Table 11 UK Stroke Diagnostics Market Size, By Technology, 2020-2030 (USD Mn, CAGR%)
Table 12 France Stroke Diagnostics Market Size, By Technology, 2020-2030 (USD Mn, CAGR%)
Table 13 Spain Stroke Diagnostics Market Size, By Technology, 2020-2030 (USD Mn, CAGR%)
Table 14 Russia Stroke Diagnostics Market Size, By Technology, 2020-2030 (USD Mn, CAGR%)
Table 15 Rest of Europe Stroke Diagnostics Market Size, By Technology, 2020-2030 (USD Mn, CAGR%)
Table 16
LIST OF FIGURES
Figure 1 North America and Europe Stroke Diagnostics Market Segmentation
Figure 2 Drivers, Restraints, Opportunities, and Challenges in the North America and Europe Stroke Diagnostics Market
Figure 3 Value Chain Analysis
Figure 4 Porter’s Five Forces Analysis
Figure 5 North America and Europe Stroke Diagnostics Market, By Technology (2020-2030)
Figure 6 North America and Europe Stroke Diagnostics Market, By Region
Figure 7 North America Stroke Diagnostics Market Snapshot
Figure 8 U.S. Stroke Diagnostics Market, 2020-2030 (USD Mn)
Figure 9 Canada Stroke Diagnostics Market, 2020-2030 (USD Mn)
Figure 10 Europe Stroke Diagnostics Market Snapshot
Figure 11 Germany Stroke Diagnostics Market, 2020-2030 (USD Mn)
Figure 12 France Stroke Diagnostics Market, 2020-2030 (USD Mn)
Figure 13 UK Stroke Diagnostics Market, 2020-2030 (USD Mn)
Figure 14 Italy Stroke Diagnostics Market, 2020-2030 (USD Mn)
Figure 15 Spain Stroke Diagnostics Market, 2020-2030 (USD Mn)
Figure 16 Russia Stroke Diagnostics Market, 2020-2030 (USD Mn)
Figure 17 Company Share Analysis
Figure 18 Boston Scientific Corp. Financial Snapshot
Figure 19 Cordis Corporation Financial Snapshot
Figure 20 GE Healthcare Financial Snapshot
Figure 21 Hitachi Medical Systems Financial Snapshot
Figure 22 Neusoft Medical Systems Financial Snapshot
Figure 23 Philips Healthcare Financial Snapshot
Figure 24 Siemens Healthcare Financial Snapshot
Figure 25 Toshiba Medical Systems Corporation Financial Snapshot
Figure 26 Medtronic Financial Snapshot
Figure 27 Stryker Financial Snapshot
Figure 28 Merck Sharp & Dohme Corp. Financial Snapshot
Figure 29 Teleflex Incorporated Financial Snapshot
Figure 30 B. Braun Melsungen AG Financial Snapshot
Figure 31 AliveCor, Inc. Financial Snapshot
Boston Scientific Corp.
Cordis Corporation
GE Healthcare
Hitachi Medical Systems
Neusoft Medical Systems
Philips Healthcare
Siemens Healthcare
Toshiba Medical Systems Corporation
Medtronic
Stryker
Merck Sharp & Dohme Corp.
Teleflex Incorporated
B. Braun Melsungen AG
AliveCor, Inc.